Evaluation of outcomes in elderly patients diagnosed with colorectal cancer
DOI:
https://doi.org/10.18203/2349-2902.isj20181101Keywords:
Colorectal cancer, Co-morbidities, Elderly, Surgery, SurvivalAbstract
Background: Colorectal cancer in the elderly carries a high morbidity and mortality. The National Bowel Cancer Audit Programme is a high-quality audit incorporating all UK colorectal cancer patients. Author analysed this database to investigate the local outcomes for this high-risk group.
Methods: Data (mode of presentation, presence of metastatic disease, treatment surgery, colonic stent or conservative and WHO performance status) was collected on all patients aged 85 years or over diagnosed with colorectal cancer at a large tertiary referral centre over a 5-year period. Ninety day and 2 year-mortality was obtained for all patients.
Results: Ninety patients (45 male, 45 female, median age 88.9 range 85.0-97.9 years) were included (47 emergency presentation, 43 elective presentation). A 18 of 47 patients underwent emergency surgery. A 90-day and 2-year mortality in this group was 17% and 69% respectively. 29 of 47 patients presenting as an emergency had non-operative treatment (2-year mortality 87%). Two years mortality for patients undergoing emergency surgery was 100% if aged above 90 years or if distant metastases were present. Eleven of 43 patients presenting electively underwent surgery. 90-day and 2-year mortality for this group was 18% and 0% respectively. Two years mortality for those presenting electively and undergoing non-operative treatment was 62%.
Conclusions: Decision making must be very carefully considered in patients aged over 85 years as the presence of metastases, poor WHO performance status or age over 90 carries with it a significant risk of mortality at both 90 days and 2 years following diagnosis.
References
Tsoi KK, Hirai HW, Chan FC, Griffiths S and Sung JJ. Predicted Increases in Incidence of Colorectal Cancer in Developed and Developing Regions, in Association with Ageing Populations. Clinical Gastroenterology and Hepatology. 2016.
Simmonds P, Best L, Baughan C. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet. 2000;356(9234):968-74.
Healthcare Quality Improvement Partnership. National Bowel Cancer Audit Annual Report Version 2. 2016.
Hamaker ME, Prins MC, Schiphorst AH, van Tuyl SAC, Pronk A, et al. Long-term changes in physical capacity after colorectal cancer treatment. Journal of Geriatric Oncology. 2015;6(2):153-64.
Damhuis RAM, Wereldsma JCJ and Wiggers T. The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer. International Journal of Colorectal Disease. 1996;11(1):45-8.
Office for National Statistics. Mortality rates. 2013.
Ugolini G, Ghignone F, Zattoni D, Veronese G, Montroni I. Personalized surgical management of colorectal cancer in elderly population. World J Gastroenterol. 2014;20(14):3762-77.
Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents. Br J Surg. 2002;89(9):1096-102.
Currie A, Christmas C, Aldean H, Mobasheri M, Bloom ITM. Systematic review of self-expanding stents in the management of benign colorectal obstruction. Colorectal Disease. 2014;16(4):239-45.
Hill J, Kay C, Morton D, Magill L, Handley K, Gray RG. CREST: Randomised phase III study of stenting as a bridge to surgery in obstructing colorectal cancer - Results of the UK Colo Rectal Endoscopic Stenting Trial (CREST). J Clinic Oncol. 2016;34(15).
